Thalassaemia

WHO SEARO Publishes Desk Review of Haemoglobinopathies in the South-East Asia Region
Actualités

WHO SEARO Publishes Desk Review of Haemoglobinopathies in the South-East Asia Region

In an effort to understand the prevalence of thalassaemic syndromes and the existent blood supply system available within each country of the South-East Asia Region, the WHO Regional Office for…
TIF Presents The Federation’s Annual Report For 2020
Actualités

TIF Presents The Federation’s Annual Report For 2020

“Our commitment to unite the patient voice and to advocate at the highest possible levels for equal access to all treatment options remains our number one priority.“ TIF President –…
Hemoglobin Disorders In Europe: A Systematic Effort Of Identifying And Addressing Unmet Needs And Challenges By TIF
Actualités

Hemoglobin Disorders In Europe: A Systematic Effort Of Identifying And Addressing Unmet Needs And Challenges By TIF

The recent population movement has led to a steady increase of carriers and patients with haemoglobin disorders, namely thalassaemia and sickle cell disease, in all countries of the European Union.…
Live Webinar on Thalassemia: Advances in 2021 with Dr M.D. Cappellini
Actualités

Live Webinar on Thalassemia: Advances in 2021 with Dr M.D. Cappellini

The past decade has witnessed path-breaking advances with regard to novel therapeutic approaches of thalassaemia and, most significantly, phenomenal developments made in the direction of gene therapy of β- thalassaemia…
Clinical Trials Update: The June 2021 Edition
Actualités

Clinical Trials Update: The June 2021 Edition

TIF provides you with comprehensive and up-to-date information on developing drugs and therapies for thalassaemia and sickle cell disease (SCD) currently in clinical trials. Our most recent June 2021 update…
TIF Is Actively Participating In The 26th EHA Annual Congress
Actualités

TIF Is Actively Participating In The 26th EHA Annual Congress

TIF is excited to be participating in the 26th EHA Annual Congress, held this year virtually on 09 – 17 June 2021. Ms Lily Cannon, TIF Operations Manager, attended a…
WORLD BLOOD DONOR DAY 2021: Give blood and keep the world beating
Blood Donation

WORLD BLOOD DONOR DAY 2021: Give blood and keep the world beating

An Overview: Every year, on 14 June, countries around the world celebrate World Blood Donor Day (WBDD). The event serves to thank voluntary, unpaid blood donors for their life-saving gifts…
Bluebirdbio Announces The Lifting Of FDA Clinical Hold for Sickle Cell Disease And β-Thalassaemia Studies
Actualités

Bluebirdbio Announces The Lifting Of FDA Clinical Hold for Sickle Cell Disease And β-Thalassaemia Studies

bluebird bio, Inc. today announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical holds on the Phase 1/2 HGB-206 and Phase 3 HGB-210 studies of LentiGlobin…
New Paper From Blood and Beyond Outlines How To Learn From The Impact Of The COVID-19 Crisis On Blood Use
Actualités

New Paper From Blood and Beyond Outlines How To Learn From The Impact Of The COVID-19 Crisis On Blood Use

The multi-stakeholder Blood and Beyond initiative recently published a policy briefing shedding light on how the COVID-19 pandemic affects blood use, blood transfusion services, and patients in whom transfusions are…
International Thalassaemia Day 2021: Official Global Press Release
Actualités

International Thalassaemia Day 2021: Official Global Press Release

On International Thalassaemia Day, TIF shines a light on the striking health inequalities that affect the global thalassaemia community, further accentuated by the ongoing coronavirus pandemic. NICOSIA, May 5, 2021/Thalassaemia International…
Bouton retour en haut de la page